{"name":"Cancer Advances Inc.","slug":"cancer-advances-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"G17DT-Irinotecan","genericName":"G17DT-Irinotecan","slug":"g17dt-irinotecan","indication":"Metastatic colorectal cancer","status":"phase_2"}]}],"pipeline":[{"name":"G17DT-Irinotecan","genericName":"G17DT-Irinotecan","slug":"g17dt-irinotecan","phase":"phase_2","mechanism":"G17DT-Irinotecan is a topoisomerase I inhibitor, which works by blocking the enzyme topoisomerase I and preventing DNA replication in cancer cells.","indications":["Metastatic colorectal cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxNOG1zUElEYzloc3RrWDNxbTFvWFhGMUU5ak9PQlliZlE1S19LX3BiUnFtVUhUbVh5Mml4emFObjUtY3QwcHBleDlZanl0blRPUElfV0E4U2xFZkJkR0FhLUYwYXlFYlBoTDdBeFlwZ2RSWGZTUlRyN0drUkNOMFQwanNlVTIweTlJZ1kzMlZrbWY5M2hPU0FIREZyVVE2cnN5VHBXdENmTVZrQ1lqU1FkeEhHSWxFVnVMY0tsekJqc3Y2S0tLQkVod0s0QlR0ZjVlekdlZ1pQU2Y3SHRfcXFKdWNYWFFBWC0tN2xqcGxPNmJRSU10S3ZHOGJB?oc=5","date":"2026-04-08","type":"pipeline","source":"Quiver Quantitative","summary":"Curanex Pharmaceuticals Reports Positive Patient Outcomes in Advanced Cancer and Critical Illness Cases Following Use of Lead Product - Quiver Quantitative","headline":"Curanex Pharmaceuticals Reports Positive Patient Outcomes in Advanced Cancer and Critical Illness Cases Following Use of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQMkJobGEtTm5DOVRfV0NkSFJTNGN2bkF3REJMR0FjcWx2OW9Hb2phQlY3dkE0ZHpGR1RpeGRsNDFkMWd2WVJQZDZpWXlJTHhvbDItam5lTDVmVnlPMkU1WXNLdXZBcmctUUk4NWdfZFhKcTI1bUZMWjJlU1F4dUFSRjQzV3Z2Q3c?oc=5","date":"2026-04-02","type":"pipeline","source":"timothysykes.com","summary":"ORIC Pharmaceuticals Faces Turbulence Amid Prostate Cancer Drug Advancements - timothysykes.com","headline":"ORIC Pharmaceuticals Faces Turbulence Amid Prostate Cancer Drug Advancements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQMk1DWWtmZEtSNzlYY0lQc1EzcnpzNW5mZEZkZUIzdU5HOFdaMG05WHllZWhyOG9lam1jZUxSTnJXRW5tR2lEVGUzVC04SDR4TmpLLTd6b2ctLUJtcXhfcWZDNWEtYS1Cb1NVZXloenZldFdIeFFwNFdZNXlBXzRVMjJrSmhET1gwN1RyVDNyLU5XQWQ3QUNQYmZuZ2g0SHI3UTktN0VFaXptMEJjelFKam9USTBCWjJxRkNCZnNFNGRaeV9La2RLVWdn?oc=5","date":"2026-03-02","type":"pipeline","source":"PBS","summary":"Novartis settles with Henrietta Lacks' estate over use of her cancer cells to advance medicine - PBS","headline":"Novartis settles with Henrietta Lacks' estate over use of her cancer cells to advance medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxPU0ZkR2NXMktwRkZyRnpuTExuNE1zNjRpSmJzQzB0N0NITksxdkU1VnRlZWlxX3pBMjZqdE8yZzJaNDBBdTR6d0g5ekc3OENDeHY5TExNZ3pmOXdPenU0S3VveW9YUm1LRHluRmRHVHhCRFBfNlBzc3lsV3pDcWJnczFuNUc5c0l6Q0Y4eHgwTU8yU0dsRHlXc1lOMGc5U21OMHFXZWJSU0VrSF94SktIMGtvLXY2NTB2cWZ5OFczd0QtNUhvUDZmM1RueVZxR21jaTZlTkppdGRXWHVBWEItNUo2Vjl6T1JuRDJoRkJVUGVEWGRRNU9HUUFTdEZWcFdqa0ppWVM0OG15VmZxc29TeU1DRnNwd1lJSjdIMWJtakpHSkg5QmRoaUxaZS1udnVwZjJkQklTRjg5UldiY2diSEtuVHJrVXcyT2E2TlpoYXYzREZM?oc=5","date":"2026-02-23","type":"deal","source":"prnewswire.com","summary":"Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer - prnewswire.com","headline":"Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgJBVV95cUxNZGlsZTB1b3dZZXEzeWsyT2lWQ3kxOC1xSUhocTA1bXFjcTdPbTQ5RXRYZDVNYmt3SVBWVGdoMGpEN0ZyV2t0Skk1M0ZvdWsxQkllNkFNMzVBemxDZklNUG1hdUU3WmE0UWs2QlpoSkJQbFBJZWVGVG5OSGc5dlFyUHBqbno4NF9pN0VFYURaeFc0cXN1OHNuTDAwUF9CUFZvZGJwQWdwUHluOENya05vSUlnN0g4LW1tdHVramx6RmlZMUYwbV8yd1VyOTBHNXl2YzQ0c0g0bDJtSi1pNGI2by1LZlBsOXRybThrNGpXNXdEbUF2c1piZTdYYjd1VV93blJPZjRRLTJrVjdEZVQ3c3psSE1WRE1LY1FMQi1LcHBPRFk0c0tLeUJtTlBRNmxiemlDSl8zTFpWYXZxNkE1UGhYeUhPZw?oc=5","date":"2026-02-10","type":"regulatory","source":"GlobeNewswire","summary":"Medicus Pharma Receives FDA “Study May Proceed” Clearance - GlobeNewswire","headline":"Medicus Pharma Receives FDA “Study May Proceed” Clearance","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-03","type":"trial","source":"Business Wire","summary":"Lantern Pharma Reports Additional Positive LP-184 Phase 1a Results Showing Durable Disease Control in Heavily Pre-Treated Advanced Cancer Patients as Company Advances Precision Oncology Program into M","headline":"Lantern Pharma Reports Additional Positive LP-184 Phase 1a Results Showing Durable Disease Control in Heavily Pre-Treate","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxON1dudkhCY0VWajFxVzZGSlRPeWxEVXdJdTR3X1NETHo0aG5LcVVlX0FUNUxhaUp1bzU1NlNsUGc1YlRDOHNYanpRM0N5dTB1S2JqeWFqVTRUT195S3ZEWFc4VHVRNFgyc095WjFuWGFrTGxWWHRfZDVLRkp2cS1mRWFMTFh5VEQ1ZVp3RzFoclBrLU9PcElOc2FtcFltM0JOdkx1N3I0VEN6bzgwNlBlbXhhemh0elRyUk9mc29nbDdfY055MFRDUkVMNHk?oc=5","date":"2025-11-17","type":"pipeline","source":"TMX Newsfile","summary":"The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet - TMX Newsfile","headline":"The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNbDBtbUVSTmVKNW1XaVFLZXNmSGJwZkVJNklRUkl5UE52U0tXdlYtUlJNSmNZeHc5X29JaE4wcmZRTUJBVzExaXZOY3JPMHlZS3FuMllsbXZMaGZoNHpXYXhVaE90bV9PUUVwX0o2S3oyUWxGU1dHaXYzVnQ5WE5DWVBHX0RqQWNpMXB6dC1EOWxrMlhpRkZnR3F3cjBlVDc2RklpeQ?oc=5","date":"2025-10-20","type":"pipeline","source":"Cedars-Sinai","summary":"Drug Combo Cuts Risk of Death in Advanced Prostate Cancer by 40% - Cedars-Sinai","headline":"Drug Combo Cuts Risk of Death in Advanced Prostate Cancer by 40% - Cedars","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQbUVaUjJGektwa1dMY0Z2emprV2NabzNTTVBmNk5VUkZUS2tzMTF1bmllbVktYy1VdkdDZG12cVB0dm1SMV9xWEJpaWpHSGY3eHhPdURzVXBQa2lMbzNCb0ZQQ1J6ckpwOGd6Y0ZOWm91enpGVHhSRUxVS041dnozc1ZITTNiSzg1cHZjQWlrQzg3LWpIQkRad3JqNmhRd25oLU91bGtTWkZocE9kYXMwSVdBeUZwd1hNSGxxaU9oZHlOdTllakpXaWlWUkZqVkd5WmlCbGtn?oc=5","date":"2025-09-23","type":"deal","source":"prnewswire.com","summary":"Illumina advances personalized cancer care with new pharma development partnerships - prnewswire.com","headline":"Illumina advances personalized cancer care with new pharma development partnerships","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPZEhoN2RTaHV5bk9qZC1kcUFWZGVhUFFxNE53amhGUXhPN1lHTEZuS19LTXR6Y2NTT01OV1JfODk4bzR0Nkd3LWxLbGtUMFlaVUs5YkJfbjA0VUlzNnhGcHNOcDE3UmlRMVRQRGp1ZlNnMmRJMS1DZVl6N1drZHZ0cVc3cXlLRzF3MHlObzJHcjE?oc=5","date":"2025-08-28","type":"pipeline","source":"Yahoo Finance","summary":"Takeda Pharmaceutical Company Limited (TAK) Advances γδ T Cell Cancer Treatments - Yahoo Finance","headline":"Takeda Pharmaceutical Company Limited (TAK) Advances γδ T Cell Cancer Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNa0VWZFZJR0YxTG8xZzFKSFZXX192NEpPeTFLckx0LVl3RzQtaFBPVzZPMW44cHE4d3MxQ0F0NTBfX29jTlRLNzdLUnlRWXNmaEdwUXY4V2ViSWY4T0lFYUptYXNzYkNvcm1Cb3h5X3llaWk3NmlYM3dndkNfMXl2a2FDczFRb0tVSndudVN6ZHc2Njl3RGlPZ3NTdkFrZ0k1N3gxb2M2ZHd4c0d0S2g2bHRGZGpzSENwUThrQy1VeDJFX2ZDQkN3b0NLSkQ4UkFz?oc=5","date":"2025-08-20","type":"pipeline","source":"BioSpace","summary":"Global Oncology Market Expands Rapidly Amid Rising Cancer Cases and Precision Medicine Advances - BioSpace","headline":"Global Oncology Market Expands Rapidly Amid Rising Cancer Cases and Precision Medicine Advances","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPQm5Bb2ZDM2VWb0hRY3VGOWFSekdBV25HVUhFVk83YzBsZlQ2VHl4T1NKS1RpcjR4T2dDUl9rOXBwaTZ6dkZJSWkzUmZTZjZNVEdwRDZOWlBLU1BQdmJzSEVkb2V4emFVTGwyUFIxOEV2emwyQUN5SlBSQ01HRVBReTRwdzR1dm5oZUZQQTNFQ3dBcGJfX1ZpV2hZYlpkdFhWZG5MSm5jV1RhcS1KVUNXRExXYXQ1SkdWX2gzbi0wMDZEZTA?oc=5","date":"2025-07-13","type":"pipeline","source":"Bloomberg.com","summary":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline - Bloomberg.com","headline":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}